Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scientific Component IV: Pharmacotherapy to Prevent Methamphetamine Relapse

NCT00442923 is registered in ClinicalTrials.gov with Aaron J. Janowsky as lead sponsor.

NCT NCT00442923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scientific Component IV: Pharmacotherapy to Prevent Methamphetamine Relapse
Lead sponsor
Aaron J. Janowsky
Phase
Phase 2
Overall status
Withdrawn
Start date
July 1, 2007
Completion date
June 30, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, relapse, substance addiction